American Society of Hematology

American Society of Hematology

Blood Journal: A Phase 1 Trial: Evaluating…Methylprednisolone: RE: ASH 2023 San Diego, CA December 9-11 Media Interviews Summary on: Phase 1 Study and others BLOOD is a very important medical journal.

read more
MedPage Today

MedPage Today

Can JAK Inhibition Help Overcome Lenalidomide Resistance in Myeloma? Early-phase experience with ruxolitinib suggests potential role in relapsed/refractory disease

read more
HemOnc Today

HemOnc Today

Multiple Myeloma regimens significantly less effective in real-world treatment settings In this study, researchers looked at a large group of patients in a registry who received a series of drug combinations for treatment of multiple myeloma. The analysis included...

read more
Healio Hematology & Oncology News

Healio Hematology & Oncology News

Healio Hematology & Oncology News: Interviewed Dr. Berenson on his perspective on Abstract 1 & Abstract 2. Questions: Reaction to results — anything surprising? Most important take home message or clinical implication.

read more
HealthTree Foundation

HealthTree Foundation

Has built many patient programs and over 8 integrated software platforms to help blood cancer patients learn more about their disease and better navigate their disease. Interviewed Dr. Berenson on phase 1 data and others. Outcomes of Triple Class Refractory Multiple...

read more
VJHemOnc

VJHemOnc

 VJHemOnc: (The Video Journal of Hematological Oncology) is an open-access video journal dedicated to providing trusted and up-to-date medical information to improve understanding of hematological cancers. Interviewed Dr. Berenson on phase 1 data and other ASH news....

read more
JAK inhibitors Transcript

JAK inhibitors Transcript

So, we've been working on this class of drugs [JAK inhibitors] now for about 5 or 6 years, both in our research laboratory and clinically. And we've uncovered a series of mechanisms that suggests that these drugs are going to be very active, probably not only in...

read more
What is Multiple Myeloma?

What is Multiple Myeloma?

Survival and treatments are improving for this type of blood cancer You don't expect to break a rib while doing light housekeeping. Similarly, you wouldn't think your worsening back pain might be caused by a type of blood cancer. However, these are among classic...

read more
KIIS Cares Interview

KIIS Cares Interview

What: Myeloma is a disease in your bone marrow. Inside your bone marrow are the cells that make your blood, your red cells, your white cells, and your platelets. This plays a key role in maintaining the strength of the bone. Why: There have been several recent...

read more
Tommy Garceau, IMBCR’s Marathon Team Captain

Tommy Garceau, IMBCR’s Marathon Team Captain

Tommy, who has been Dr. Berenson’s able assistant for many years, has a passion for athletics and training. In July 2013, he started Team IMBCR at a time when he was also participating in several marathons, half-marathons and trail running and half iron distance...

read more
Multiple Myeloma: ‘Old Rules’ No Longer Apply

Multiple Myeloma: ‘Old Rules’ No Longer Apply

Original Article Writen by: Robert Carlson - Oncology Times NEW YORK—Treatment regimens for relapsed/refractory multiple myeloma have become plentiful in the past few years, with a panoply of options. Consequently, “the old rules no longer apply,” says James Berenson,...

read more
NBC News Special Correspondent Tom Brokaw

NBC News Special Correspondent Tom Brokaw

In response to NBC News Special Correspondent Tom Brokaw’s announcement that he has been diagnosed with multiple myeloma, a rare blood cancer of malignant cells found in the bone marrow, leading physician Dr. James Berenson is encouraged that Mr. Brokaw is receiving...

read more
Dedication of “Determination”

Dedication of “Determination”

The Institute for Myeloma & Bone Cancer Research (IMBCR) is pleased to announce the dedication of a newly designed artwork for IMBCR. Artist, Ted Kirby, named the artwork “Determination”, in honor of all those who are determined to cure Multiple Myeloma. Please...

read more